A61K 31/7105
Natural ribonucleic acids, i.e. containing only riboses attached to adenine, guanine, cytosine
Official title: Natural ribonucleic acids, i.e. containing only riboses attached to adenine, guanine, cytosine or uracil and having 3'-5' phosphodiester links
A61K31/7105 (Natural ribonucleic acids, i.e. containing only riboses attached to adenine, guanine, cytosine) appears on 2,097 US grants and 4,974 published applications in this corpus.
Search patents in A61K- Granted patents
- 2,097
- Published applications
- 4,974
- Assignees
- 1,758
- Inventors
- 9,461
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1983 | 1 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 2 | 0 |
| 1998 | 6 | 0 |
| 1999 | 5 | 0 |
| 2000 | 2 | 0 |
| 2001 | 4 | 2 |
| 2002 | 3 | 9 |
| 2003 | 3 | 17 |
| 2004 | 5 | 11 |
| 2005 | 0 | 10 |
| 2006 | 3 | 25 |
| 2007 | 2 | 35 |
| 2008 | 4 | 41 |
| 2009 | 10 | 81 |
| 2010 | 13 | 89 |
| 2011 | 26 | 120 |
| 2012 | 45 | 153 |
| 2013 | 79 | 208 |
| 2014 | 120 | 232 |
| 2015 | 135 | 211 |
| 2016 | 124 | 230 |
| 2017 | 129 | 174 |
| 2018 | 128 | 250 |
| 2019 | 142 | 328 |
| 2020 | 154 | 319 |
| 2021 | 165 | 330 |
| 2022 | 203 | 443 |
| 2023 | 141 | 351 |
| 2024 | 157 | 431 |
| 2025 | 166 | 418 |
| 2026 | 120 | 456 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Assisted loading of hydrophobic molecules into liposomes6 Oct 2026US 12,751,922 B2University of Connecticut
- Pumpless encapsulation of messenger RNA29 Sep 2026US 12,746,203 B2Translate Bio, Inc.
- Long-acting low-toxicity novel cationic lipid compounds and composition thereof29 Sep 2026US 12,746,208 B2Beijing Youcare Kechuang Pharmaceutical Technology Co., Ltd.
- Stealth lipid nanoparticle compositions for cell targeting29 Sep 2026US 12,746,209 B2Generation Bio Co.
- Methods of loading extracellular vesicles29 Sep 2026US 12,746,291 B2Lonza Sales AG
- Steroid-cationic lipid compound and use thereof8 Oct 2026US 2026/0306406 A1Cansino (Shanghai) Biological Research Co., Ltd.
- Sik inhibitors to treat chronic kidney disease8 Oct 2026US 2026/0306463 A1The General Hospital Corporation
- Hydrogel ink, hydrogel and uses thereof8 Oct 2026US 2026/0306528 A1
- Methods and materials for treating cancer8 Oct 2026US 2026/0306566 A1Mayo Foundation for Medical Education and Research
- Lipid nanoparticles and methods of manufacture and use thereof8 Oct 2026US 2026/0306659 A1Ablynx N. V.
Most cited
By later US patents
- Genetic inhibition by double-stranded RNA1,185US 6,506,559 B1Carnegie Institute of Washington · 2003
- Cationic lipids and methods for the delivery of therapeutic agents380US 8,569,256 B2Protiva Biotherapeutics, Inc. · 2013
- Lipid encapsulated interfering RNA265US 7,799,565 B2Protiva Biotherapeutics, Inc. · 2010
- Immune stimulation by phosphorothioate oligonucleotide analogs238US 5,663,153 AIsis Pharmaceuticals, Inc. · 1997
- DLIN-KC2-DMA lipid nanoparticle delivery of modified polynucleotides189US 8,754,062 B2Moderna Therapeutics, Inc. · 2014